The analysis of the CPTAC database showed that in comparison with the surrounding healthy tissues, RBM10 protein level was considerably increased in UCEC, breast cancer, colon cancer, KIRC, OV, HNSC, LUAD, GBM, and hepatocellular carcinoma (HCC) (Figure S2A). Here, RBM10 is linked to colonic neoplasm.